420 related articles for article (PubMed ID: 11465088)
1. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
2. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
3. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
4. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
5. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
6. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
[TBL] [Abstract][Full Text] [Related]
7. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
Scand J Immunol; 1997 Jul; 46(1):103-8. PubMed ID: 9246215
[TBL] [Abstract][Full Text] [Related]
8. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
[TBL] [Abstract][Full Text] [Related]
9. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.
van de Wal Y; Kooy Y; van Veelen P; Peña S; Mearin L; Papadopoulos G; Koning F
J Immunol; 1998 Aug; 161(4):1585-8. PubMed ID: 9712018
[TBL] [Abstract][Full Text] [Related]
10. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
[TBL] [Abstract][Full Text] [Related]
11. Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.
Ráki M; Dahal-Koirala S; Yu H; Korponay-Szabó IR; Gyimesi J; Castillejo G; Jahnsen J; Qiao SW; Sollid LM
Gastroenterology; 2017 Sep; 153(3):787-798.e4. PubMed ID: 28535873
[TBL] [Abstract][Full Text] [Related]
12. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
13. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
[TBL] [Abstract][Full Text] [Related]
14. Celiac sprue: correlation with murine T cell responses to wheat gliadin components.
Kagnoff MF; Austin RK; Johnson HC; Bernardin JE; Dietler MD; Kasarda DD
J Immunol; 1982 Dec; 129(6):2693-7. PubMed ID: 6183341
[TBL] [Abstract][Full Text] [Related]
15. Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro.
Hoffmann K; Alminger M; Andlid T; Chen T; Olsson O; Sandberg AS
J Agric Food Chem; 2009 Nov; 57(21):10150-5. PubMed ID: 19813732
[TBL] [Abstract][Full Text] [Related]
16. Tissue transglutaminase--the key player in celiac disease: a review.
Reif S; Lerner A
Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
[TBL] [Abstract][Full Text] [Related]
17. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
18. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
[TBL] [Abstract][Full Text] [Related]
20. Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation.
Kumar R; Eastwood AL; Brown ML; Laurie GW
J Mol Biol; 2002 Jun; 319(3):593-602. PubMed ID: 12054857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
